Miniature models of human organs may provide a more accurate predictor of drug efficacy than animal testing.

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Recent breakthroughs in making stem-cell based human embryo models are raising urgent questions about to what extent they should be treated like natural embryos and whether they are open to misuse.

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...

Media contact: Jeff Hansen Ho-Wook Jun, Ph.D., Photography: Steve Wood A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied ...

The authors believe their results reveal that human computer simulation drug trials are a powerful tool for predicting arrhythmia. They anticipate that the methodology could be integrated into current ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

Liver toxicity is a big problem in the drug, food, and consumer products industries, especially because results in animal models fail to predict how chemicals will affect humans. A new Liver-Chip ...

Walter and Eliza Hall Institute researchers have genetically engineered a new laboratory model that enables accurate testing of anti-cancer drugs by mimicking the complexity of human cancers.

Last year, Congress passed a law allowing drug makers to collect safety and efficacy data using high-tech new tools, including bioengineered organs, organs on chips and computer models, instead of ...